ACRIVON THERAPEUTICS INCORPORATED (ACRV)
Track the next or latest earnings date for ACRIVON THERAPEUTICS INCORPORATED, review consensus estimates, and see cached AI analysis for recent quarterly results.
Recent earnings news
finance.yahoo.com · 2026-07-30T23:04:57
Shareholders back management alignment, yet a $12.5 million net loss and declining book value weigh on the quarter.
ACRES Commercial Realty Q2 Earnings: $12.5M Loss | ACR Stock Newsstocktitan.net · 2026-07-29T20:11:00
The REIT posted a GAAP loss of $1.87 per diluted share; CEO Mark Fogel cited a healthy loan pipeline, with a results call set for July 30.
The Strategic Buyers That Could Scoop Up Distressed eVTOL Darling Archer Aviation - 24/7 Wall St.247wallst.com · 2026-07-29T12:10:42
A short list of corporate giants has the motive, money, and strategic logic to make a move on Archer Aviation before someone else does.
Brokerages Set Acrivon Therapeutics, Inc. (NASDAQ:ACRV) PT at $11.67 - American Market Newsamericanbankingnews.com · 2026-07-29T03:18:57
(NASDAQ:ACRV – Get Free Report) have earned a consensus rating of “Moderate Buy” from the five brokerages that are currently covering the company, MarketBeat reports. One investment analyst has rated the stock with a sell rating and four have issued a buy rating on the company.
Archer Aviation vs. Rivian Automotive: Which EV Vehicle Stock Is a Better Buy in 2026?finance.yahoo.com · 2026-07-28T18:38:01
Both companies are burning cash heavily, but their paths to profitability, and risk profiles, diverge sharply.
Upcoming earnings date
Time not specified
Fiscal quarter: 2026-06-30
EPS estimate: -$0.49
Revenue estimate: N/A
Market cap: $65.06M
Analysis snapshot
No cached AI earnings analysis is available for this stock yet. Check back after the company reports or open the app to generate a fresh analysis.
Recent earnings history
Browse the calendar week| Date | Quarter | Report window | EPS est. | Revenue est. |
|---|---|---|---|---|
| Aug 12, 2026 | 2026-06-30 | Time not specified | -$0.49 | N/A |